New SEC Suit

[Anonymous]

DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Hospira Inc. (“Hospira”) (NYSE: HSP) concerning the sale to Pfizer Inc. Under the terms of the agreement, Hospira shareholders will only receive $90.00 in cash for each share owned.

 

[Anonymous]

The investigation centers on whether Hospira’s Board of Directors is acting in the shareholders’ best interests, whether the board considered alternatives to the acquisition, and whether the board has employed an adequate process to review and act on the proposed transaction. The $17 billion transaction is expected to close in the second half of 2015.


HR